Furthermore, to assess the potential of SPRED3 as a prognostic marker for patients with thyroid carcinoma (THCA), RNAseq and clinical data from the TCGA-THCA datasets were obtained and organized using the STAR process. This evidence concerns the gene SPRED3 and thyroid gland carcinoma.